Market Overview:
The global liquid embolics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of brain tumors and other neurological disorders, rising demand for minimally invasive surgeries, and technological advancements in liquid embolics products. Based on type, the global liquid embolics market is segmented into isobutyl-2-cyanoacrylate (IBCA), ethanol, sodium morrhuate, Bletilla striata, and others. IBCA is expected to account for the largest share of the global liquid embolics market in 2018. This can be attributed to its superior adhesive properties as compared to other types of liquid embolics products available in the market. Based on application, the global Liquid Embolic Market is segmented into tumor and brain cancer; brain arteriovenous malformations (AVMs); ischemic stroke; brain aneurysm; and others.
Product Definition:
Liquid embolics are substances used to occlude blood vessels. They can be used to stop bleeding or to prevent the spread of cancer.
Isobutyl-2-Cyanoacrylate(IBCA):
Isobutyl-2-cyanoacrylate (IBCA) is a clear, colorless liquid with a strong odor. It's molecular structure is similar to that of acrylates but the functional group attached to it is different. IBCA has been used in various industries such as cosmetics, adhesives/sealants and plastics among others.
Ethanol:
Ethanol is a type of alcohol that can be derived from various sources including grains, fruits, and sugar. It has been used as a fuel in vehicles and as an additive to gasoline for decades. Ethyl alcohol or ethanol is the most common form of the substance and was first discovered by accident in 1827 when French scientists were trying to find out why wine turned into vinegar when it was kept at a high temperature.
Application Insights:
The tumor and brain cancer segment dominated the global liquid embolics market in 2017, accounting for a share of over 40.0% by revenue. The application is projected to witness significant growth during the forecast period due to its rising use in the treatment of brain cancer and other tumors. Liquid embolic agents are used as a safe and effective alternative for treating various cancers such as glioma, meningioma, acoustic neurinoma, pilocytic astrocytoma/glioblastoma multiforme & others.
Ischemic stroke is another major segment that is expected to grow rapidly during the forecast period owing to its increasing prevalence globally coupled with few treatment options available for this condition post-stroke onset.
Regional Analysis:
North America dominated the global liquid embolics market in 2017. This is due to presence of a large number of manufacturers and suppliers coupled with high adoption rate for advanced treatment options. In addition, increasing prevalence of brain tumor and stroke are also expected to drive the regional demand for LECs over the forecast period. Europe followed North America in terms of market share owing to rising incidence rates associated with ischemic stroke, aneurysm rupture, intracranial tumors & malignant hypertension among others which are driving growth across this region.
Asia Pacific was valued at USD X million in 2017.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global liquid embolics market is expected to benefit from the increasing demand for minimally invasive surgeries. This is because liquid embolics are used in these surgeries to seal blood vessels and other tissues.
- Rising prevalence of cancer: The global liquid embolics market is also expected to benefit from the rising prevalence of cancer. This is because liquid embolics are used in cancer treatments to stop the bleeding and control the spread of tumors.
- Growing number of surgical procedures: The global liquid embolics market is also expected to benefit from the growing number of surgical procedures being performed each year. This is because surgeons use liquid embolics during surgery to prevent blood loss and control tissue damage.
Scope Of The Report
Report Attributes
Report Details
Report Title
Liquid Embolics Market Research Report
By Type
Isobutyl-2-Cyanoacrylate(IBCA), Ethanol, Sodium Morrhuate, Bletilla Striata, Others
By Application
Tumor and Brain Cancer, Brain Arteriovenous Malformations, Ischemic Stroke, Brain Aneurysm, Others
By Companies
Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed, Mizuho America, RauMedic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Liquid Embolics Market Report Segments:
The global Liquid Embolics market is segmented on the basis of:
Types
Isobutyl-2-Cyanoacrylate(IBCA), Ethanol, Sodium Morrhuate, Bletilla Striata, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tumor and Brain Cancer, Brain Arteriovenous Malformations, Ischemic Stroke, Brain Aneurysm, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- St. Jude Medical
- Cyberonics
- Codman & Shurtleff
- Stryker
- Integra LifeSciences
- InoMed
- Mizuho America
- RauMedic
Highlights of The Liquid Embolics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Isobutyl-2-Cyanoacrylate(IBCA)
- Ethanol
- Sodium Morrhuate
- Bletilla Striata
- Others
- By Application:
- Tumor and Brain Cancer
- Brain Arteriovenous Malformations
- Ischemic Stroke
- Brain Aneurysm
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liquid Embolics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liquid embolics is a rare and potentially life-threatening condition in which blood vessels in the brain burst. This can cause serious damage to the brain, including death.
Some of the major companies in the liquid embolics market are Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed, Mizuho America, RauMedic.
The liquid embolics market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Liquid Embolics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Liquid Embolics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Liquid Embolics Market - Supply Chain
4.5. Global Liquid Embolics Market Forecast
4.5.1. Liquid Embolics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Liquid Embolics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Liquid Embolics Market Absolute $ Opportunity
5. Global Liquid Embolics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Liquid Embolics Market Size and Volume Forecast by Type
5.3.1. Isobutyl-2-Cyanoacrylate(IBCA)
5.3.2. Ethanol
5.3.3. Sodium Morrhuate
5.3.4. Bletilla Striata
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Liquid Embolics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Liquid Embolics Market Size and Volume Forecast by Application
6.3.1. Tumor and Brain Cancer
6.3.2. Brain Arteriovenous Malformations
6.3.3. Ischemic Stroke
6.3.4. Brain Aneurysm
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Liquid Embolics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Liquid Embolics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Liquid Embolics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Liquid Embolics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Liquid Embolics Demand Share Forecast, 2019-2026
9. North America Liquid Embolics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Liquid Embolics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Liquid Embolics Market Size and Volume Forecast by Application
9.4.1. Tumor and Brain Cancer
9.4.2. Brain Arteriovenous Malformations
9.4.3. Ischemic Stroke
9.4.4. Brain Aneurysm
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Liquid Embolics Market Size and Volume Forecast by Type
9.7.1. Isobutyl-2-Cyanoacrylate(IBCA)
9.7.2. Ethanol
9.7.3. Sodium Morrhuate
9.7.4. Bletilla Striata
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Liquid Embolics Demand Share Forecast, 2019-2026
10. Latin America Liquid Embolics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Liquid Embolics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Liquid Embolics Market Size and Volume Forecast by Application
10.4.1. Tumor and Brain Cancer
10.4.2. Brain Arteriovenous Malformations
10.4.3. Ischemic Stroke
10.4.4. Brain Aneurysm
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Liquid Embolics Market Size and Volume Forecast by Type
10.7.1. Isobutyl-2-Cyanoacrylate(IBCA)
10.7.2. Ethanol
10.7.3. Sodium Morrhuate
10.7.4. Bletilla Striata
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Liquid Embolics Demand Share Forecast, 2019-2026
11. Europe Liquid Embolics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Liquid Embolics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Liquid Embolics Market Size and Volume Forecast by Application
11.4.1. Tumor and Brain Cancer
11.4.2. Brain Arteriovenous Malformations
11.4.3. Ischemic Stroke
11.4.4. Brain Aneurysm
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Liquid Embolics Market Size and Volume Forecast by Type
11.7.1. Isobutyl-2-Cyanoacrylate(IBCA)
11.7.2. Ethanol
11.7.3. Sodium Morrhuate
11.7.4. Bletilla Stiata
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Liquid Embolics Demand Share, 2019-2026
12. Asia Pacific Liquid Embolics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Liquid Embolics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Liquid Embolics Market Size and Volume Forecast by Application
12.4.1. Tumor and Brain Cancer
12.4.2. Brain Arteriovenous Malformations
12.4.3. Ischemic Stroke
12.4.4. Brain Aneurysm
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Liquid Embolics Market Size and Volume Forecast by Type
12.7.1. Isobutyl-2-Cyanoacrylate(IBCA)
12.7.2. Ethanol
12.7.3. Sodium Morrhuate
12.7.4. Bletilla Striata
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Liquid Embolics Demand Share, 2019-2026
13. Middle East & Africa Liquid Embolics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Liquid Embolics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Liquid Embolics Market Size and Volume Forecast by Application
13.4.1. Tumor and Brain Cancer
13.4.2. Brain Arteriovenous Malformations
13.4.3. Ischemic Stroke
13.4.4. Brain Aneurysm
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Liquid Embolics Market Size and Volume Forecast by Type
13.7.1. Isobutyl-2-Cyanoacrylate(IBCA)
13.7.2. Ethanol
13.7.3. Sodium Morrhuate
13.7.4. Bletilla Striata
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Liquid Embolics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Liquid Embolics Market: Market Share Analysis
14.2. Liquid Embolics Distributors and Customers
14.3. Liquid Embolics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St. Jude Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cyberonics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Codman & Shurtleff
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Stryker
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Integra LifeSciences
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. InoMed
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mizuho America
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. RauMedic
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
